MAPK activity was heightened in both Nras-overexpressing models, albeit to a stronger extent in NrasG12D-driven HCC (Fig. 1f and Supplementary Fig. 1a, l), suggesting differential MAPK intensity downstream of distinct Nras point mutations. Here, NRAS is linked to hepatocellular carcinoma.